Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Safety, immunogenicity, and surrogate markers of clinical efficacy for modified vaccinia Ankara as a smallpox vaccine in HIV-infected subjects.

Greenberg RN, Overton ET, Haas DW, Frank I, Goldman M, von Krempelhuber A, Virgin G, Bädeker N, Vollmar J, Chaplin P.

J Infect Dis. 2013 Mar 1;207(5):749-58. doi: 10.1093/infdis/jis753. Epub 2012 Dec 7.

2.

Clinical development of Modified Vaccinia virus Ankara vaccines.

Gilbert SC.

Vaccine. 2013 Sep 6;31(39):4241-6. doi: 10.1016/j.vaccine.2013.03.020. Epub 2013 Mar 21. Review.

PMID:
23523410
3.

Third-generation smallpox vaccines: challenges in the absence of clinical smallpox.

Meseda CA, Weir JP.

Future Microbiol. 2010 Sep;5(9):1367-82. doi: 10.2217/fmb.10.98. Review.

PMID:
20860482
4.

Monitoring of human immunological responses to vaccinia virus.

Harrop R, Ryan MG, Golding H, Redchenko I, Carroll MW.

Methods Mol Biol. 2004;269:243-66. Review.

PMID:
15114020
5.

IMVAMUNE: modified vaccinia Ankara strain as an attenuated smallpox vaccine.

Kennedy JS, Greenberg RN.

Expert Rev Vaccines. 2009 Jan;8(1):13-24. doi: 10.1586/14760584.8.1.13. Review.

PMID:
19093767
6.

New generation smallpox vaccines: a review of preclinical and clinical data.

Artenstein AW.

Rev Med Virol. 2008 Jul-Aug;18(4):217-31. doi: 10.1002/rmv.571. Review.

PMID:
18283712
7.

Modified Vaccinia Virus Ankara: History, Value in Basic Research, and Current Perspectives for Vaccine Development.

Volz A, Sutter G.

Adv Virus Res. 2017;97:187-243. doi: 10.1016/bs.aivir.2016.07.001. Epub 2016 Aug 1. Review.

PMID:
28057259
8.

The immunology of smallpox vaccines.

Kennedy RB, Ovsyannikova IG, Jacobson RM, Poland GA.

Curr Opin Immunol. 2009 Jun;21(3):314-20. doi: 10.1016/j.coi.2009.04.004. Epub 2009 Jun 11. Review.

9.

Vaccinia viruses: vaccines against smallpox and vectors against infectious diseases and tumors.

Walsh SR, Dolin R.

Expert Rev Vaccines. 2011 Aug;10(8):1221-40. doi: 10.1586/erv.11.79. Review.

10.

The effects of post-exposure smallpox vaccination on clinical disease presentation: addressing the data gaps between historical epidemiology and modern surrogate model data.

Keckler MS, Reynolds MG, Damon IK, Karem KL.

Vaccine. 2013 Oct 25;31(45):5192-201. doi: 10.1016/j.vaccine.2013.08.039. Epub 2013 Aug 27. Review.

11.

Therapeutic vaccination to treat chronic infectious diseases: current clinical developments using MVA-based vaccines.

Boukhebza H, Bellon N, Limacher JM, Inchauspé G.

Hum Vaccin Immunother. 2012 Dec 1;8(12):1746-57. doi: 10.4161/hv.21689. Epub 2012 Aug 16. Review.

12.

Cytokine production associated with smallpox vaccine responses.

Simon WL, Salk HM, Ovsyannikova IG, Kennedy RB, Poland GA.

Immunotherapy. 2014;6(10):1097-112. doi: 10.2217/imt.14.72. Review.

13.

Vaccinia Virus LC16m8∆ as a Vaccine Vector for Clinical Applications.

Kidokoro M, Shida H.

Vaccines (Basel). 2014 Oct 17;2(4):755-71. doi: 10.3390/vaccines2040755. Review.

14.

Smallpox vaccines for biodefense.

Kennedy RB, Ovsyannikova I, Poland GA.

Vaccine. 2009 Nov 5;27 Suppl 4:D73-9. doi: 10.1016/j.vaccine.2009.07.103. Review.

15.

Insights on common vaccinations in HIV-infection: efficacy and safety.

Nicolini LA, Giacobbe DR, Di Biagio A, Viscoli C.

J Prev Med Hyg. 2015 Jun 10;56(1):E28-32. Review.

Supplemental Content

Support Center